Investment & Finance
Europe Now a Growth Priority for North American Cannabis Capital
North American institutional cannabis investors now see the European medical market as a crucial driver of growth, a new survey suggests.
aurora
36stories
8 Octlast updated
More in aurora
- Uncategorized
Canadian Medical Cannabis Clinic Launches 3000-Participant Study into Emerging Cannabis Treatments
Canadian medical cannabis clinic Santé Cannabis has started recruitment for a new study assessing the effectiveness of various cannabis treatment plans.
- Cultivation
Germany’s Domestic Cannabis Cultivation Market Poised for Significant Growth as 3 New Licences Issued
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has now issued the first three new licences for domestic cannabis cultivation, expected to see the amount of product grown in the country at least double this year.
- Uncategorized
Canadian Cannabis Stocks Rally On Appointment Of Industry Veteran To Key Lobby Group
The Cannabis Council of Canada (C3), the country’s most prominent lobbying group, has announced the appointment of industry veteran Paul McCarthy as its new president.
- Uncategorized
Aurora Agrees To Settle Class Action Lawsuit For Undisclosed Sum
Aurora Cannabis has agreed to settle a class action lawsuit regarding allegations it artificially inflated its profits in 2019.
- Medical
French Authorities Confirm Flower Will Not Be Included In Medical Cannabis Programme
The French National Medicines Safety Agency (ANSM) has confirmed that flowers will not be included in its upcoming generalised medical cannabis framework.
- Companies
Aurora Plans 1:10 Share Consolidation to Avoid NASDAQ Delisting
Canadian cannabis giant Aurora yesterday announced plans to enact a 1:10 stock consolidation in order to avoid delisting from the NASDAQ stock exchange.
- Uncategorized
Aurora Signs C$38.8m Deal To Pay Down Debt
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Uncategorized
Aurora Reports 50% Revenue Jump as International Sales Climb
Aurora Cannabis reported skyrocketing revenues alongside falling losses in Q1 of the 2024 fiscal year, seeing its stock price increase around 5%.
